Usana Health Sciences (USNA) Operating Leases (2021 - 2022)
Usana Health Sciences' (USNA) quarterly Operating Leases came in at $7.1 million in Q1 2022, down 17.83% year-over-year from $8.6 million in Q1 2021, and down 17.83% quarter-over-quarter from $8.6 million in Q1 2021.
Powered by 
Analysis
Usana Health Sciences (USNA) Operating Leases (2021 - 2022) Analysis & Trends
Usana Health Sciences (USNA) has reported Operating Leases for 2 consecutive years, with $7.1 million the latest figure, recorded in Q1 2022.
- On a quarterly basis, Operating Leases fell 17.83% year-over-year to $7.1 million in Q1 2022; TTM through Jan 2022 was $7.1 million, a 17.83% decrease from a year earlier, with the FY2022 full-year figure at $7.1 million, down 17.83% from the prior year.
- Operating Leases was $7.1 million for Q1 2022 at Usana Health Sciences, down from $8.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $8.6 million in Q1 2021 and troughed at $7.1 million in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.36 Bn | 68.99 Bn | 3.30 Bn |
| 2 | Kenvue | 34.27 Bn | 33.16 Bn | 2.30 Bn |
| 3 | Kimberly Clark | 32.95 Bn | 31.99 Bn | 1.60 Bn |
| 4 | Bath & Body Works | 3.76 Bn | 2.97 Bn | 692.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.33 Bn | 2.27 Bn | - |
| 6 | Perrigo | 1.97 Bn | 1.57 Bn | 313.90 Mn |
| 7 | Herbalife | 1.27 Bn | 896.04 Mn | 1.03 Bn |
| 8 | Edgewell Personal Care | 1.23 Bn | 837.00 Mn | 242.50 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - |
| 10 | Usana Health Sciences | 277.20 Mn | 108.64 Mn | 174.93 Mn |